Shareholder Seeks To Halt $1.2B Clinical Data Sale
A Clinical Data Corp. shareholder filed a putative class action Tuesday in Delaware against the drug company's board of directors in an attempt to halt its $1.2 billion acquisition by Forest...To view the full article, register now.
Already a subscriber? Click here to view full article